280 related articles for article (PubMed ID: 31305924)
1. Treatment of Children With GH in the United States and Europe: Long-Term Follow-Up From NordiNet® IOS and ANSWER Program.
Sävendahl L; Polak M; Backeljauw P; Blair J; Miller BS; Rohrer TR; Pietropoli A; Ostrow V; Ross J
J Clin Endocrinol Metab; 2019 Oct; 104(10):4730-4742. PubMed ID: 31305924
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Safety of Growth Hormone Treatment in Childhood: Two Large Observational Studies: NordiNet IOS and ANSWER.
Sävendahl L; Polak M; Backeljauw P; Blair JC; Miller BS; Rohrer TR; Hokken-Koelega A; Pietropoli A; Kelepouris N; Ross J
J Clin Endocrinol Metab; 2021 May; 106(6):1728-1741. PubMed ID: 33571362
[TBL] [Abstract][Full Text] [Related]
3. Real-life GH dosing patterns in children with GHD, TS or born SGA: a report from the NordiNet® International Outcome Study.
Blankenstein O; Snajderova M; Blair J; Pournara E; Pedersen BT; Petit IO
Eur J Endocrinol; 2017 Aug; 177(2):145-155. PubMed ID: 28522645
[TBL] [Abstract][Full Text] [Related]
4. Early GH Treatment Is Effective and Well Tolerated in Children With Turner Syndrome: NordiNet® IOS and Answer Program.
Backeljauw P; Blair JC; Ferran JM; Kelepouris N; Miller BS; Pietropoli A; Polak M; Sävendahl L; Verlinde F; Rohrer TR
J Clin Endocrinol Metab; 2023 Sep; 108(10):2653-2665. PubMed ID: 36947589
[TBL] [Abstract][Full Text] [Related]
5. Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS).
Blanco-López A; Antillón-Ferreira C; Saavedra-Castillo E; Barrientos-Pérez M; Rivero-Escalante H; Flores-Caloca O; Calzada-León R; Rosas-Guerra CC; Koledova E; Chiquete E; Ayala-Estrada A
J Endocrinol Invest; 2020 Oct; 43(10):1447-1452. PubMed ID: 32239476
[TBL] [Abstract][Full Text] [Related]
6. Management and interpretation of heterogeneous observational data: using insulin-like growth factor-I data from the NordiNet® International Outcome Study.
Blankenstein O; Pedersen BT; Schlumpf M; Andreasen AH; Júlíusson PB
Growth Horm IGF Res; 2015 Feb; 25(1):41-6. PubMed ID: 25542446
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program.
Biller BMK; Höybye C; Carroll P; Gordon MB; Birkegård AC; Kelepouris N; Nedjatian N; Weber MM
Pituitary; 2021 Aug; 24(4):611-621. PubMed ID: 33709288
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone replacement in adults: Real-world data from two large studies in US and Europe.
Weber MM; Gordon MB; Höybye C; Jørgensen JOL; Puras G; Popovic-Brkic V; Molitch ME; Ostrow V; Holot N; Pietropoli A; Biller BMK
Growth Horm IGF Res; 2020 Feb; 50():71-82. PubMed ID: 31972476
[TBL] [Abstract][Full Text] [Related]
9. Clinical Indications for Growth Hormone Therapy.
Danowitz M; Grimberg A
Adv Pediatr; 2022 Aug; 69(1):203-217. PubMed ID: 35985710
[TBL] [Abstract][Full Text] [Related]
10. Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study.
Sävendahl L; Maes M; Albertsson-Wikland K; Borgström B; Carel JC; Henrard S; Speybroeck N; Thomas M; Zandwijken G; Hokken-Koelega A
J Clin Endocrinol Metab; 2012 Feb; 97(2):E213-7. PubMed ID: 22238393
[TBL] [Abstract][Full Text] [Related]
11. Still too little, too late? Ten years of growth hormone therapy baseline data from the NordiNet® International Outcome Study.
Polak M; Konrad D; Tønnes Pedersen B; Puras G; Šnajderová M
J Pediatr Endocrinol Metab; 2018 Apr; 31(5):521-532. PubMed ID: 29652668
[TBL] [Abstract][Full Text] [Related]
12. Ten years with biosimilar rhGH in clinical practice in Sweden - experience from the prospective PATRO children and adult studies.
Lundberg E; Kriström B; Zouater H; Deleskog A; Höybye C
BMC Endocr Disord; 2020 Apr; 20(1):55. PubMed ID: 32349731
[TBL] [Abstract][Full Text] [Related]
13. Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years.
Ross JL; Lee PA; Gut R; Germak J
Growth Horm IGF Res; 2015 Dec; 25(6):286-93. PubMed ID: 26363846
[TBL] [Abstract][Full Text] [Related]
14. Is growth hormone treatment in children associated with weight gain?--longitudinal analysis of KIGS data.
Reinehr T; Lindberg A; Koltowska-Häggström M; Ranke M
Clin Endocrinol (Oxf); 2014 Nov; 81(5):721-6. PubMed ID: 24750131
[TBL] [Abstract][Full Text] [Related]
15. Early growth hormone treatment start in childhood growth hormone deficiency improves near adult height: analysis from NordiNet® International Outcome Study.
Polak M; Blair J; Kotnik P; Pournara E; Pedersen BT; Rohrer TR
Eur J Endocrinol; 2017 Nov; 177(5):421-429. PubMed ID: 28780521
[TBL] [Abstract][Full Text] [Related]
16. The NordiNet® International Outcome Study and NovoNet® ANSWER Program®: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therapy (Norditropin®).
Höybye C; Sävendahl L; Christesen HT; Lee P; Pedersen BT; Schlumpf M; Germak J; Ross J
Clin Epidemiol; 2013; 5():119-27. PubMed ID: 23658497
[TBL] [Abstract][Full Text] [Related]
17. Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER.
Biller BMK; Höybye C; Ferran JM; Kelepouris N; Nedjatian N; Olsen AH; Weber MM; Gordon MB
J Endocr Soc; 2023 May; 7(6):bvad054. PubMed ID: 37197408
[TBL] [Abstract][Full Text] [Related]
18. Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database.
Bakker NE; Lindberg A; Heissler J; Wollmann HA; Camacho-Hübner C; Hokken-Koelega AC;
J Clin Endocrinol Metab; 2017 May; 102(5):1702-1711. PubMed ID: 28323917
[TBL] [Abstract][Full Text] [Related]
19. Gender influences short-term growth hormone treatment response in children.
Sävendahl L; Blankenstein O; Oliver I; Christesen HT; Lee P; Pedersen BT; Rakov V; Ross J
Horm Res Paediatr; 2012; 77(3):188-94. PubMed ID: 22508317
[TBL] [Abstract][Full Text] [Related]
20. Current indications for growth hormone therapy for children and adolescents.
Richmond E; Rogol AD
Endocr Dev; 2010; 18():92-108. PubMed ID: 20523020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
